AbbVie is a global biopharmaceutical company known for its innovative approach to addressing some of the world's most complex and serious diseases. The company has a strong portfolio of products, particularly in immunology and oncology, and has made significant investments in research and development. AbbVie's acquisition of Allergan has also expanded its product offerings and market reach. However, the company faces challenges such as patent expirations, regulatory hurdles, and intense competition in the pharmaceutical industry. AbbVie must continue to innovate and diversify its portfolio to sustain its growth and market position.